Clinical Trial Update: A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial of BLI-1300 ointment for symptomatic perianal Crohn's disease was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Perianal Crohn Disease

Drugs mentioned

• BLI-1300

Snippet

Sponsor: Braintree Laboratories | Conditions: Perianal Crohn's Disease | Phase 2 | Status: TERMINATED | Results posted: 2023-11-13